Literature DB >> 11374732

Study of effectiveness of bezafibrate in the treatment of chronic hepatitis C.

T Kurihara, A Niimi, A Maeda, M Shigemoto, K Yamashita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11374732     DOI： 10.1111/j.1572-0241.2001.03831.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  3 in total

1.  Pioglitazone decreases hepatitis C viral load in overweight, treatment naïve, genotype 4 infected-patients: a pilot study.

Authors:  Mario Chojkier; Hisham Elkhayat; Dina Sabry; Michael Donohue; Martina Buck
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

2.  Peroxisome proliferator-activated receptors in HCV-related infection.

Authors:  Sébastien Dharancy; Maud Lemoine; Philippe Mathurin; Lawrence Serfaty; Laurent Dubuquoy
Journal:  PPAR Res       Date:  2009-03-30       Impact factor: 4.964

Review 3.  PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection.

Authors:  Marialuigia Fantacuzzi; Rosa Amoroso; Alessandra Ammazzalorso
Journal:  Biology (Basel)       Date:  2022-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.